Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease

Claudia Mandato1, Stefania Lucariello, Maria Rosario Licenziati

  • 1Department of Pediatrics, European Laboratory for the Investigation of Food-Induced Diseases, University of Naples, Naples, Italy.

Insights

Pediatric obesity-related liver disease involves insulin resistance, oxidative stress, and inflammation. These factors are key to understanding and treating liver issues in obese children.

Area of Science:

  • Pediatric Endocrinology
  • Hepatology
  • Metabolic Disorders

Background:

  • Pediatric obesity is a growing health concern.
  • Obesity is linked to various comorbidities, including liver disease.
  • Non-alcoholic fatty liver disease (NAFLD) is a common manifestation in obese children.

Purpose of the Study:

  • To investigate metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease.
  • To differentiate these factors between obese children with and without liver abnormalities.

Main Methods:

  • Study included 50 obese children (ages 7-14).
  • Participants were divided into two groups: with (n=20) and without (n=30) hypertransaminasemia and ultrasonographic liver brightness.
  • Assessed insulin resistance (fasting glucose/insulin ratio [FGIR]), leptin, iron, transferrin, ferritin, C-reactive protein (CRP), white blood cell (WBC) count, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, C282Y and H63D mutations, and erythrocytic glutathione peroxidase (GPX) activity.

Main Results:

  • Group 1 (with liver issues) showed significantly higher FGIR, serum ferritin, CRP, and GPX activity compared to Group 2.
  • FGIR, ferritin, and CRP were simultaneously abnormal in 41% of Group 1 patients.
  • No significant differences were found in leptin, iron, transferrin, WBC, TNF-alpha, IL-6, or iron mutation status between the groups.

Conclusions:

  • Insulin resistance, oxidative stress, and low-grade systemic inflammation are implicated in pediatric obesity-related liver disease.
  • These pathophysiological mechanisms offer targets for therapeutic interventions.
  • Findings support the development of targeted trials for hepatopathic obese children.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...